Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

NCT05564286 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Nasopharyngeal Cancer
Chemotherapy-induced Nausea and Vomiting
Radiation-Induced Nausea and Vomiting
Antiemetic

Interventions

DRUG: Fosaprepitant
DRUG: tropisetron
DRUG: Dexamethasone

Sponsor

Shantou University Medical College